Anthrax Vaccines Market by Vaccine Type (Live Vaccines, Cell free PA Vaccines), Distribution Channel, Application, Region, Global Industry Analysis, Market Distribution Channel, Share, Growth, Trends, and Forecast 2019 to 2026
Published On: July 2019
 
Report ID:399166
 
 
Pages: 250




Global anthrax vaccines market is expected to reach USD 879.5 Million by 2026 at a CAGR of 9.3% during the forecast period 2019-2026. Rising instances of the diseases and growing need of personalized medicines are the two factors which may propel growth of the anthrax vaccines market.

Market Overview:

Anthrax is defined as a serious disease which may impact both animals and humans. It is caused by bacteria called Bacillus anthracis. Humans can catch anthrax from contact with infected animals, wool, meat, or hides. Anthrax vaccine, which was licensed in 1970, immunizes against anthrax disease. Based on limited but sound evidence, the vaccine protects against both cutaneous (skin) and inhalation anthrax.

Report Description:

  • The base year for the study has been considered 2018, historic year 2016 and 2017 and the forecast period considered is from 2019 to 2026. The anthrax vaccines market is analysed on the basis of value (USD Million) and volume (Tons).
  • The study delivers a comprehensive analysis of global anthrax vaccines market by vaccine type, application, distribution channel and regions.
  • The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
  • Porter’s Five Forces model is used in order to recognize the competitive scenario in the anthrax vaccines market. This report incorporates the industry analysis which is focused on providing an extensive view of the anthrax vaccines market.
  • The study also includes attractiveness analysis of vaccine type, application, distribution channel and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
  • The report provides company profile of the key players operating in the anthrax vaccines market and a comparative analysis based on their business overviews, industry analysis, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial analysis.
  • The market estimates have been evaluated by considering the effect of different political, economic, social, technological and legal factors which are based on our extensive secondary research, primary research, and in-house databases.

Global Anthrax Vaccines Market Key Findings:

All the segments have been analysed on global, regional and country basis. The study includes the analysis of more than 30 countries for each segment.

Segmentation Analysis:

The anthrax vaccines market is segmented on the basis of vaccine type, application and distribution channel.

  • The vaccine type segment is classified as live vaccines and cell-free PA vaccines. The live vaccines segment is growing with the highest CAGR of 11.6% in the forecast period. The live vaccine contains spores from attenuated strains of Bacillus anthracis.
  • The distribution channel segment is divided into segments such as hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment is dominating the market and valued around USD 220.24 Million in 2018. The anthrax vaccines are mostly sold in hospital pharmacies.
  • The application segment includes human use and animal use. Animal use segment is dominating the market with the highest share of 61.50% in 2018. A high proportion of anthrax vaccines are used for animal.

Regional Segmentation Analysis:

The regions analysed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. North America region dominated the global anthrax vaccines market with USD 183.03 Million in 2018 where as the Asia Pacific is a rapidly growing region in the market.

  • North America is dominating the market owing to government initiatives to prevent the spread of anthrax and the existence of many ongoing programs under organizations like HHS-CDC, BARDA, ASPR, NIAID, and the FDA which are stimulating the growth of the market.
  • Asia Pacific is a rapidly growing region due to the rising investments in the R&D sector. Also, the widespread vaccine production facilities across Japan coupled with the presence of sophisticated healthcare infrastructure in the country is also leading to market growth.

Global Anthrax Vaccines Market Competitive Analysis:    

Key players in the anthrax vaccines market are Emergent BioSolutions, Merial, Merck, Zoetis , Bayer Sanidad Animal, Colorado Serum, PharmAthene, Tiankang, Biogénesis-Bago, CAVAC, Rosenbusch, Agrovet, Vecol, CVCRI, IVPM, Prondil, CDV, Indian Immunologicals, Botswana Vaccine Institute, Ceva Santé Animale, Intervac, JOVAC, and among others. For instance, in March 2019, Emergent BioSolutions Inc., a significant player in the market announced that it has started a phase III study to assess AV7909 for the post-exposure prevention of anthrax disease. The phase III program will determine the lot immunogenicity, consistency, and safety of AV7909 (anthrax vaccine adsorbed with CPG 7909 adjuvant) after a two-dose schedule, administered intramuscularly in healthy adult patients.

*All our reports are customizable as per customer requirements                                 

This study forecasts revenue growth and volume at global, regional, and country levels from 2016 to 2026. Fior Markets has segmented the global anthrax vaccines market on the basis of below mentioned segments:

Global Anthrax Vaccines Market, By Vaccine Type:

  • Live Vaccines
  • Cell free PA Vaccines

Global Anthrax Vaccines Market, By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Global Anthrax Vaccines Market, By Application:                                          

  • Human Use
  • Animal Use

Global Antibiotics Market, By Regions:

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Asia-Pacific
  • Japan
  • China
  • India
  • South America
  • Brazil
  • Middle East and Africa         
  • UAE
  • South Africa
  1. INTRODUCTION
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. RESEARCH SCOPE
    4. CURRENCY
  2. RESEARCH METHODOLOGY AND ASSUMPTIONS
  3. EXECUTIVE SUMMARY
  4. PREMIUM INSIGHTS
    1. TOP INVESTMENT POCKETS
      1. GLOBAL ANTHRAX VACCINES MARKET ATTRACTIVENESS ANALYSIS BY VACCINE TYPE
      2. GLOBAL ANTHRAX VACCINES MARKET ATTRACTIVENESS ANALYSIS BY DISTRIBUTION CHANNEL
      3. GLOBAL ANTHRAX VACCINES MARKET ATTRACTIVENESS ANALYSIS BY APPLICATION
      4. GLOBAL ANTHRAX VACCINES MARKET ATTRACTIVENESS ANALYSIS BY REGION
    2. PORTER’S FIVE FORCES ANALYSIS
      1. THREAT OF NEW ENTRANTS
      2. THREAT OF SUBSTITUTES
      3. BARGAINING POWER OF SUPPLIERS
      4. BARGAINING POWER OF BUYERS
      5. INTENSITY OF COMPETITIVE RIVALRY
    3. PESTEL ANALYSIS
    4. INDUSTRY SWOT ANALYSIS
    5. INDUSTRY TRENDS
    6. MICRO AND MACRO FACTORS AFFECTING GLOBAL ANTHRAX VACCINES MARKET
    7. PRICING ANALYSIS
      1. PRICING ASSUMPTIONS
      2. PRICE PROJECTIONS PER REGION
    8. MACRO-ECONOMIC FACTORS
      1. SUPPLY SIDE
      2. DEMAND SIDE
    9. TRADE MAP ANALYSIS (IMPORT-EXPORT DATA)
    10. COUNTRY LEVEL ANALYSIS
    11. PENETRATION & GROWTH PROSPECT MAPPING
    12. INDUSTRY VALUE CHAIN ANALYSIS
      1. RAW MATERIALS ANALYSIS
      2. SUPPLIER ANALYSIS
      3. END USER ANALYSIS
    13. CUSTOMERS/BUYERS BY REGIONS
  5. MARKET DYNAMICS
    1. MARKET EVALUATION
    2. DRIVERS
      1. GROWING INSTANCES OF THE DISEASE
      2. INCREASED EATING OF UNDERCOOKED OR RAW MEAT FROM INFECTED ONLINE PHARMACIES
      3. GROWING NEED OF PERSONALIZED MEDICINES
      4. THE PRESENCE OF LARGE TARGET POPULATION IN DEVELOPING MARKETS.
    3. RESTRAINTS
      1. LOW RATE OF VOLUNTARY SCREENING FOR THE ANTHRAX DISEASE
    4. OPPORTUNITIES
      1. THE COST-EFFECTIVENESS OF IMMUNIZATIONS, NEW INVESTMENTS OPPORTUNITIES FROM GOVERNMENT, RESEARCH FOUNDATIONS, DONORS, ADVANCES IN RESEARCH AND MANUFACTURING TECHNOLOGIES IS ANTICIPATED TO FUEL THE MARKET GROWTH IN THE FORECAST PERIOD
    5. CHALLENGES
      1. LACK OF AWARENESS, COST-PROHIBITIVE VACCINATION IN UNDER-DEVELOPED NATIONS, SCARCITY OF AVAILABILITY AND AFFORDABILITY MAY POSE A CHALLENGE TO THE MARKET
  6. GLOBAL ANTHRAX VACCINES MARKET ANALYSIS AND FORECAST, BY VACCINE TYPE
    1. SEGMENT OVERVIEW
    2. LIVE VACCINES
    3. CELL FREE PA VACCINES
  7. GLOBAL ANTHRAX VACCINES MARKET ANALYSIS AND FORECAST, BY DISTRIBUTION CHANNEL
    1. SEGMENT OVERVIEW
    2. HOSPITAL PHARMACIES
    3. HOSPITAL PHARMACIES
    4. ONLINE PHARMACIES
  8. GLOBAL ANTHRAX VACCINES MARKET ANALYSIS AND FORECAST, BY APPLICATION
    1. SEGMENT OVERVIEW
    2. HUMAN USE
    3. ANIMAL USE
  9. GLOBAL ANTHRAX VACCINES MARKET ANALYSIS AND FORECAST, BY REGIONAL ANALYSIS
    1. SEGMENT OVERVIEW
    2. NORTH AMERICA
      1. U.S.
      2. CANADA
      3. MEXICO
    3. EUROPE
      1. GERMANY
      2. FRANCE
      3. U.K.
      4. ITALY
      5. SPAIN
      6. REST OF EUROPE
    4. ASIA-PACIFIC
      1. JAPAN
      2. CHINA
      3. INDIA
      4. REST OF APAC
    5. SOUTH AMERICA
      1. BRAZIL
      2. REST OF SOUTH AMERICA
    6. MIDDLE EAST AND AFRICA
      1. UAE
      2. SOUTH AFRICA
      3. REST OF MEA
  10. GLOBAL ANTHRAX VACCINES MARKET-COMPETITIVE LANDSCAPE
    1. OVERVIEW
    2. MARKET SHARE OF KEY PLAYERS IN THE ANTHRAX VACCINES MARKET
      1. GLOBAL COMPANY MARKET SHARE
      2. NORTH AMERICA COMPANY MARKET SHARE
      3. EUROPE COMPANY MARKET SHARE
      4. APAC COMPANY MARKET SHARE
    3. COMPETITIVE SITUATIONS AND TRENDS
      1. PRODUCT LAUNCHES AND DEVELOPMENTS
      2. PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS
      3. MERGERS & ACQUISITIONS
      4. EXPANSIONS
  11. COMPANY PROFILES
    1. EMERGENT BIOSOLUTIONS
      1. BUSINESS OVERVIEW
      2. COMPANY SNAPSHOT
      3. KEY FINANCIAL
        1. REVENUE ANALYSIS
        2. PRICE ANALYSIS
        3. COST ANALYSIS
        4. VOLUME ANALYSIS
        5. MARGIN ANALYSIS
        6. COMPANY SEGMENT ANALYSIS
      4. COMPANY PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
      6. SWOT ANALYSIS
    2. MERIAL
    3. MERCK
    4. BAYER SANIDAD ANIMAL
    5. COLORADO SERUM
    6. PHARMATHENE
    7. TIANKANG
    8. BIOGÉNESIS-BAGO
    9. ROSENBUSCH
    10. AGROVET
    11. VECOL
    12. CVCRI
    13. IVPM
    14. PRONDIL
    15. CDV
    16. INDIAN IMMUNOLOGICALS
    17. BOTSWANA VACCINE INSTITUTE
    18. CEVA SANTÉ ANIMALE
    19. INTERVAC
    20. JOVAC

LIST OF TABLE

  1. GLOBAL ANTHRAX VACCINES MARKET, BY VACCINE TYPE, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)
  2. GLOBAL LIVE VACCINES IN ANTHRAX VACCINES MARKET, BY REGION, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)
  3. GLOBAL CELL FREE PA VACCINES IN ANTHRAX VACCINES MARKET, BY REGION, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)
  4. GLOBAL ANTHRAX VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)
  5. GLOBAL HOSPITAL PHARMACIES IN ANTHRAX VACCINES MARKET, BY REGION, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)
  6. GLOBAL RETAIL PHARMACIES IN ANTHRAX VACCINES MARKET, BY REGION, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)
  7. GLOBAL ONLINE PHARMACIES IN ANTHRAX VACCINES MARKET, BY REGION, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)
  8. GLOBAL ANTHRAX VACCINES MARKET, BY APPLICATION, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)
  9. GLOBAL HUMAN USE IN ANTHRAX VACCINES MARKET, BY REGION, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)
  10. GLOBAL ANIMAL USE IN ANTHRAX VACCINES MARKET, BY REGION, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)
  11. GLOBAL ANTHRAX VACCINES MARKET, BY REGION, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)
  12. NORTH AMERICA ANTHRAX VACCINES MARKET, BY VACCINE TYPE, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)
  13. NORTH AMERICA ANTHRAX VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)
  14. NORTH AMERICA ANTHRAX VACCINES MARKET, BY APPLICATION, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)
  15. U.S. ANTHRAX VACCINES MARKET, BY VACCINE TYPE, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)
  16. U.S. ANTHRAX VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)
  17. U.S. ANTHRAX VACCINES MARKET, BY APPLICATION, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)
  18. CANADA ANTHRAX VACCINES MARKET, BY VACCINE TYPE, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)
  19. CANADA ANTHRAX VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)
  20. CANADA ANTHRAX VACCINES MARKET, BY APPLICATION, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)
  21. MEXICO ANTHRAX VACCINES MARKET, BY VACCINE TYPE, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)
  22. MEXICO ANTHRAX VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)
  23. MEXICO ANTHRAX VACCINES MARKET, BY APPLICATION, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)
  24. EUROPE ANTHRAX VACCINES MARKET, BY VACCINE TYPE, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)
  25. EUROPE ANTHRAX VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)
  26. EUROPE ANTHRAX VACCINES MARKET, BY APPLICATION, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)
  27. GERMANY ANTHRAX VACCINES MARKET, BY VACCINE TYPE, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)
  28. GERMANY ANTHRAX VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)
  29. GERMANY ANTHRAX VACCINES MARKET, BY APPLICATION, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)
  30. FRANCE ANTHRAX VACCINES MARKET, BY VACCINE TYPE, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)
  31. FRANCE ANTHRAX VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)
  32. FRANCE ANTHRAX VACCINES MARKET, BY APPLICATION, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)
  33. U.K. ANTHRAX VACCINES MARKET, BY VACCINE TYPE, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)
  34. U.K. ANTHRAX VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)
  35. U.K. ANTHRAX VACCINES MARKET, BY APPLICATION, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)
  36. ITALY ANTHRAX VACCINES MARKET, BY VACCINE TYPE, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)
  37. ITALY ANTHRAX VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)
  38. ITALY ANTHRAX VACCINES MARKET, BY APPLICATION, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)
  39. SPAIN ANTHRAX VACCINES MARKET, BY VACCINE TYPE, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)
  40. SPAIN ANTHRAX VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)
  41. SPAIN ANTHRAX VACCINES MARKET, BY APPLICATION, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)
  42. ASIA PACIFIC ANTHRAX VACCINES MARKET, BY VACCINE TYPE, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)
  43. ASIA PACIFIC ANTHRAX VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)
  44. ASIA PACIFIC ANTHRAX VACCINES MARKET, BY APPLICATION, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)
  45. JAPAN ANTHRAX VACCINES MARKET, BY VACCINE TYPE, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)
  46. JAPAN ANTHRAX VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)
  47. JAPAN ANTHRAX VACCINES MARKET, BY APPLICATION, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)
  48. CHINA ANTHRAX VACCINES MARKET, BY VACCINE TYPE, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)
  49. CHINA ANTHRAX VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)
  50. CHINA ANTHRAX VACCINES MARKET, BY APPLICATION, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)
  51. INDIA ANTHRAX VACCINES MARKET, BY VACCINE TYPE, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)
  52. INDIA ANTHRAX VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)
  53. INDIA ANTHRAX VACCINES MARKET, BY APPLICATION, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)
  54. SOUTH AMERICA ANTHRAX VACCINES MARKET, BY VACCINE TYPE, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)
  55. SOUTH AMERICA ANTHRAX VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)
  56. SOUTH AMERICA ANTHRAX VACCINES MARKET, BY APPLICATION, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)
  57. BRAZIL ANTHRAX VACCINES MARKET, BY VACCINE TYPE, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)
  58. BRAZIL ANTHRAX VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)
  59. BRAZIL ANTHRAX VACCINES MARKET, BY APPLICATION, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)
  60. MIDDLE EAST AND AFRICA ANTHRAX VACCINES MARKET, BY VACCINE TYPE, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)
  61. MIDDLE EAST AND AFRICA ANTHRAX VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)
  62. MIDDLE EAST AND AFRICA ANTHRAX VACCINES MARKET, BY APPLICATION, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)
  63. UAE ANTHRAX VACCINES MARKET, BY VACCINE TYPE, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)
  64. UAE ANTHRAX VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)
  65. UAE ANTHRAX VACCINES MARKET, BY APPLICATION, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)
  66. SOUTH AFRICA ANTHRAX VACCINES MARKET, BY VACCINE TYPE, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)
  67. SOUTH AFRICA ANTHRAX VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)
  68. SOUTH AFRICA ANTHRAX VACCINES MARKET, BY APPLICATION, 2016–2026 REVENUE (USD MILLION), VOLUME (TONS), PRICE (USD/TON)

LIST OF FIGURES 

  1. GLOBAL ANTHRAX VACCINES MARKET SEGMENTATION
  2. ANTHRAX VACCINES MARKET: RESEARCH METHODOLOGY
  3. MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  4. MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  5. DATA TRIANGULATION
  6. PORTER’S FIVE FORCES ANALYSIS
  7. VALUE CHAIN ANALYSIS
  8. TRADE MAP
  9. GLOBAL ANTHRAX VACCINES MARKET ATTRACTIVENESS ANALYSIS BY VACCINE TYPE
  10. GLOBAL ANTHRAX VACCINES MARKET ATTRACTIVENESS ANALYSIS BY DISTRIBUTION CHANNEL
  11. GLOBAL ANTHRAX VACCINES MARKET ATTRACTIVENESS ANALYSIS BY APPLICATION
  12. GLOBAL ANTHRAX VACCINES MARKET ATTRACTIVENESS ANALYSIS BY REGION
  13. GLOBAL ANTHRAX VACCINES MARKET: DYNAMICS
  14. GLOBAL ANTHRAX VACCINES MARKET SHARE BY VACCINE TYPE (2018 & 2026)
  15. GLOBAL ANTHRAX VACCINES MARKET SHARE BY DISTRIBUTION CHANNEL (2018 & 2026)
  16. GLOBAL ANTHRAX VACCINES MARKET SHARE BY APPLICATION (2018 & 2026)
  17. GLOBAL ANTHRAX VACCINES MARKET SHARE BY REGION (2018 & 2026)
  18. GLOBAL ANTHRAX VACCINES MARKET SHARE BY COMPANY (2018)


Please fill the form below, to recieve the report sample

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*

Please fill the form below for enquiry

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*
   Our Clients
  • \


Copyright © 2019 Fior Market Research LLP, All Rights Reserved.